Clinical Trials Browser

Withdrawn × Fallopian Tube Neoplasms × atezolizumab × Clear all

NCT04510584 2023-06-06

Maintenance Treatment With Bevacizumab and Atezolizumab for Ovarian Cancer

Phase 2 Withdrawn

Fallopian Tube Neoplasms